Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
NCT03153670

3T MRI in Patients With Deep Brain Stimulation (DBS)

Led by University Health Network, Toronto · Updated on 2024-05-08

250

Participants Needed

1

Research Sites

704 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Deep brain stimulation (DBS) is an established treatment for advanced Parkinson's disease, medically refractory tremor, dystonia and obsessive compulsive disorder. Several hypotheses driven DBS trials are underway to study modulation of circuit dysfunction in other neurological and psychiatric disorders like epilepsy, Alzheimer's disease and depression. Recent reports suggest profound effects of DBS on the anatomy and function of downstream areas in the brain. For example electrical stimulation of limbic circuits is associated with increase in hippocampal neurogenesis. Similarly, stimulation of subthalamic nucleus (STN) or globus pallidus (GPi) results in activation of cortical motor circuits. Non-invasive imaging modalities are increasingly being employed in these investigations to better understand the effects of DBS on the structure and function of the brain. There have been important advances in MRI and we now have MRI which provides higher resolution and higher quality brain images. More specifically, the investigators propose to use MRI to perform functional magnetic resonance imaging (i.e. fMRI) to assess the effects of deep brain stimulation on brain function and to assess whether fMRI can be used as an adjunct to improve clinical practice in these patients.

CONDITIONS

Official Title

3T MRI in Patients With Deep Brain Stimulation (DBS)

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 85 years
  • Planned to undergo, or have undergone implantation of DBS electrodes
  • Able to understand the purpose of the research and sign the informed consent form
  • Understand that the study aims to enhance understanding of brain function without direct benefit to the participant
Not Eligible

You will not qualify if you...

  • Serious cognitive or psychological impairments preventing informed consent
  • Inability to communicate effectively, including speech deficits such as dysarthria or aphasia
  • Non-English speaking

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Toronto Western Hospital

Toronto, Ontario, Canada, M5T2S8

Actively Recruiting

Loading map...

Research Team

A

Alexandre Boutet, MD/MSc

CONTACT

T

Tasnuva Hoque, BHA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here